RENU
Live / Allowed — Published for opposition (as of 15 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99324028
- Mark type
- Word mark
- Filed
- 06 Aug 2025
- Published for opposition
- 04 Aug 2026
- Attorney of record
- Joshua S. Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating degenerative disease of the articulating joints.
Owner
- Prime Merger Sub, LLC, Birmingham, AL, US
- Prime Merger Sub, LLC, Birmingham, AL, US
Prior registrations
Board proceedings on this mark
- Extension of Time to Oppose No. 99324028 — Bausch & Lomb Incorporated v. Prime Merger Sub, LLC, filed 03 Sept 2026 (Terminated)
Prosecution history
- 14 Oct 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Sept 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2026 — PUBLISHED FOR OPPOSITION
- 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION WRITTEN
- 19 Dec 2025 — ASSIGNED TO EXAMINER